Bausch Health Companies Inc. (BHC): Price and Financial Metrics

BHC POWR Grades

• BHC scores best on the Value dimension, with a Value rank ahead of 97.94% of US stocks.
• The strongest trend for BHC is in Quality, which has been heading up over the past 179 days.
• BHC ranks lowest in Sentiment; there it ranks in the 4th percentile.

BHC Stock Summary

• BHC's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.08 -- higher than only 1.2% of US-listed equities with positive expected earnings growth.
• BHC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.44% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, BAUSCH HEALTH COMPANIES INC is reporting a growth rate of 12,278.57%; that's higher than 99.85% of US stocks.
• If you're looking for stocks that are quantitatively similar to BAUSCH HEALTH COMPANIES INC, a group of peers worth examining would be MULN, CCLP, AHT, ATUS, and SFT.
• Visit BHC's SEC page to see the company's official filings. To visit the company's web site, go to www.bauschhealth.com.

BHC Valuation Summary

• BHC's EV/EBIT ratio is 13.4; this is 68.55% higher than that of the median Healthcare stock.
• BHC's price/sales ratio has moved down 8.6 over the prior 243 months.

Below are key valuation metrics over time for BHC.

BHC Growth Metrics

Its 5 year revenue growth rate is now at -11.13%.
• Its year over year cash and equivalents growth rate is now at 29.95%.
• Its 5 year price growth rate is now at 16.78%.

Over the past 15 months, BHC's revenue has gone down $351,000,000.

The table below shows BHC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	8,127	-1,179	254
2022-06-30	8,192	648	43
2022-03-31	8,325	920	-407
2021-12-31	8,434	1,426	-948
2021-09-30	8,451	1,796	-1,170
2021-06-30	8,478	1,488	-1,287

BHC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BHC has a Quality Grade of C, ranking ahead of 53.93% of graded US stocks.
• BHC's asset turnover comes in at 0.276 -- ranking 162nd of 680 Pharmaceutical Products stocks.
• CCXI, NBY, and LLY are the stocks whose asset turnover ratios are most correlated with BHC.

The table below shows BHC's key quality metrics over time.